Home•Our Research•Publications•The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia

The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia

Thematic Area:
Therapeutics
Disease Area:
Epilepsy
Research Focus:
Drug DiscoveryInflammation
Collaborators:
Academic